Johnson & Johnson to pay $5.6M for Risperdal death

Johnson & Johnson’s Janssen Pharmaceuticals unit was hit with a $5.6 million verdict by a California jury on October 16 over the death of Leo Liu during the company’s clinical study of Risperdal, a well-known anti-psychotic medication. The victim’s mother, Marion Liu, said that her son participated in Janssen’s human drug trial and that he died when Janssen’s employees did nothing to treat his heart condition during the drug trial.

Due to the jury’s finding that Janssen Research and Development LLC was 70% responsible for Liu’s death in the trial, the Johnson & Johnson subsidiary has been ordered to pay the $5.6 million to Liu’s family. Liu’s psychiatrist, Madeleine Valencerina, was also implemented in the trial. Valencierina allegedly received a payout from Janssen for convincing Liu to join the drug trial; she is being held liable for the remaining 30% of the settlement, bringing the total up to $8 million.

Risperdal is known to cause new or exacerbated conditions in patients who take it for anti-psychosis, and our team of lawyers at Williams Kherkher want you to know that you may be able to recover compensation for your suffering as a result of this drug. Call us today at (800) 220-9341 to learn more.

SEO for Lawyers